About: Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.73 (+0.54%)
IVA NASDAQ Inventiva Sa
Inventiva Sa share price
Atividade de preço de IVA
Último preço
$ 3,730
Variação (24h)
0,02 USD (0,54%)
Volume
1.43M
Volume (média 4 sem.)
-
Abertura
$ 3,75
Variação do dia
$ 3,68 - $ 3,86
Fechamento anterior
$ 3,71
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
IVA price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals